Sertraline Tablets (IP)

1. Product Introduction

Sertraline is a selective serotonin reuptake inhibitor (SSRI) antidepressant used for major depressive disorder and certain anxiety-related disorders. This product brief confirms Sertraline Hydrochloride equivalent to Sertraline 50 mg per film-coated tablet, IP standard. Healthy Life Pharma Pvt. Ltd. is identified as manufacturer and Healthy Inc as exporter in the supplied information; verify manufacturing and export credentials before publishing.

2. Product Specifications

3. Manufacturing Technology

Important manufacturing considerations for low-dose sertraline tablets include active-ingredient identity, uniform distribution, compression consistency, dissolution performance, appropriate film coating and stability. Specific granulation processes, polymorph controls, equipment, coating colours and split-tablet claims require validation and should not be assumed for this product.

4. Quality Assurance

Product quality control should follow the applicable registered IP specification, including identification, assay, uniformity of dosage units, dissolution, related substances, microbial requirements where applicable, and stability. Release limits and shelf life must be supported by approved analytical methods and actual stability data rather than generic figures.

5. Therapeutic Uses

Sertraline is an SSRI that inhibits neuronal serotonin reuptake. Depending on jurisdiction and patient age, approved indications may include major depressive disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, social anxiety disorder and premenstrual dysphoric disorder. It is not an antipsychotic. Indications and age restrictions must follow the locally approved prescribing information.

6. Export and Regulatory Support

For B2B supply and registration, request current manufacturing licences, product registration details, GMP evidence, certificate of analysis, stability and packaging data, and applicable CTD/ACTD dossier availability. WHO-GMP, Star Export House, COPP and Free Sale Certificate claims should be confirmed by supporting documentation before use in commercial or regulatory materials.

7. Frequently Asked Questions

8. Dosage and Administration

Prescription only. The starting dose, titration schedule and maximum dose depend on the diagnosis, age, liver function, other medicines and the locally approved label. Sertraline is commonly administered once daily, with or without food, but patients must follow their prescriber’s instructions. Do not split a tablet unless its approved labeling permits it.

9. Side Effects and Precautions

Possible adverse effects include nausea, diarrhoea, sleep changes, sweating, tremor and sexual dysfunction. Antidepressants carry warnings about increased suicidal thoughts or behaviour in some children, adolescents and young adults; close monitoring is important, especially early in treatment and after dose changes. Serious risks include serotonin syndrome, abnormal bleeding (especially with NSAIDs or anticoagulants), hyponatraemia and activation of mania in susceptible patients. Avoid concurrent MAO inhibitors and follow required washout periods. Seek urgent help for suicidal thoughts, severe agitation, high fever with muscle rigidity or serious allergic reactions.

10. Storage Instructions

Store in the original container or blister, protected from excess heat and moisture, and out of reach of children. Follow the approved package label for the exact storage temperature and expiry period; a 36-month shelf life has not been independently confirmed.